Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$82.84 - $88.09 $14,331 - $15,239
-173 Reduced 7.06%
2,278 $198,000
Q4 2023

Mar 18, 2024

SELL
$69.43 - $83.43 $32,701 - $39,295
-471 Reduced 16.12%
2,451 $201,000
Q3 2023

Dec 18, 2023

SELL
$78.22 - $90.4 $7,900 - $9,130
-101 Reduced 3.34%
2,922 $228,000
Q1 2023

May 15, 2023

SELL
$76.72 - $87.58 $6,751 - $7,707
-88 Reduced 2.83%
3,023 $243,000
Q4 2022

Feb 15, 2023

SELL
$76.18 - $87.74 $2,894 - $3,334
-38 Reduced 1.21%
3,111 $241,000
Q3 2022

Nov 16, 2022

BUY
$80.75 - $95.31 $10,174 - $12,009
126 Added 4.17%
3,149 $254,000
Q2 2022

Aug 16, 2022

BUY
$87.4 - $113.09 $8,740 - $11,309
100 Added 3.42%
3,023 $272,000
Q4 2020

Feb 16, 2021

BUY
$100.57 - $117.14 $293,966 - $342,400
2,923 New
2,923 $342,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $117B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Core First Bank & Trust Portfolio

Follow Core First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Core First Bank & Trust with notifications on news.